VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.796
EU - Europa 1.577
AS - Asia 1.243
SA - Sud America 225
AF - Africa 220
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.072
Nazione #
US - Stati Uniti d'America 2.710
IT - Italia 618
SG - Singapore 586
CN - Cina 439
IE - Irlanda 291
BR - Brasile 205
UA - Ucraina 165
CI - Costa d'Avorio 136
DE - Germania 125
BE - Belgio 107
NL - Olanda 74
CA - Canada 72
RU - Federazione Russa 60
SN - Senegal 58
VN - Vietnam 54
KR - Corea 50
GB - Regno Unito 48
IN - India 43
SE - Svezia 27
TR - Turchia 13
CH - Svizzera 12
MX - Messico 9
PL - Polonia 9
IR - Iran 8
NG - Nigeria 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
AR - Argentina 6
AU - Australia 6
BD - Bangladesh 6
FI - Finlandia 6
JP - Giappone 6
EC - Ecuador 5
FR - Francia 5
GR - Grecia 5
IQ - Iraq 5
MA - Marocco 5
KE - Kenya 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
IL - Israele 3
PK - Pakistan 3
SA - Arabia Saudita 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
ES - Italia 2
KZ - Kazakistan 2
RO - Romania 2
TW - Taiwan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HK - Hong Kong 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LT - Lituania 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.072
Città #
Santa Clara 481
Singapore 378
Chandler 373
Chicago 303
Dublin 290
Jacksonville 160
Civitanova Marche 145
Abidjan 136
Catania 125
Boardman 123
Hefei 99
Dallas 89
Ashburn 87
Andover 75
Cambridge 75
Lawrence 75
Grafing 73
Nanjing 71
Beijing 66
Dakar 58
Los Angeles 56
Rotterdam 53
Toronto 51
Wingene 50
Seoul 49
Quintano 41
Wilmington 40
Dong Ket 39
Des Moines 38
Houston 35
Brussels 31
San Mateo 30
Agrigento 29
The Dalles 26
Columbus 23
Nanchang 21
Paternò 21
Council Bluffs 20
Hebei 19
Munich 19
São Paulo 19
Kochi 17
Ottawa 15
Saint Petersburg 15
Bremen 14
Jiaxing 14
Shenyang 12
Tianjin 12
Changsha 11
Nijmegen 11
New York 10
Izegem 9
Abuja 8
Guangzhou 8
Hanoi 8
London 8
Manchester 8
Pune 8
Ardabil 7
Bari 7
Gravina di Catania 7
Jinan 7
San Francisco 7
Seattle 7
Stockholm 7
Zhengzhou 7
Boston 6
Brno 6
Ho Chi Minh City 6
Knoxville 6
Kunming 6
Redmond 6
Redwood City 6
Reggio Emilia 6
Tokyo 6
Valledolmo 6
Warsaw 6
Düsseldorf 5
Edinburgh 5
Falls Church 5
Leawood 5
Messina 5
Moscow 5
Mumbai 5
New Delhi 5
Palermo 5
Pescara 5
Rome 5
Zonnebeke 5
Aci Castello 4
Amsterdam 4
Antea 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Brasília 4
Bronte 4
Campinas 4
Chennai 4
Curitiba 4
Totale 4.406
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 201
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 134
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 128
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 109
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 104
Comparative proteomic analysis of insulin receptor isoform A and B signaling 100
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 100
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 100
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 96
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation 96
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 95
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 94
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 91
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 90
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 90
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 90
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 87
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 85
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 84
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 83
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 82
Insulin receptor isoforms in physiology and disease: An updated view 81
PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis 80
Insulin resistance: Any role in the changing epidemiology of thyroid cancer? 80
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 80
Abstract 4612: In breast cancer cells IGF-I induces upregulation of DDR1 by suppressing miR-199a-5p via the PI3K/Akt pathway 79
BRAF(V600E) mutation and the biology of papillary thyroid cancer 78
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 77
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 77
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 77
The IGF system in thyroid cancer:new concepts 75
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 74
p53 family proteins in thyroid cancer 73
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 72
Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study” 72
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 71
p73 tumor-suppressor activity is impaired in human thyroid cancer 70
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 70
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 70
Metabolic alterations of thyroid cancer as potential therapeutic targets 70
The p53-homologue p63 may promote thyroid cancer progression 69
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 69
Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study 68
Insulin receptor isoforms in cancer 68
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 68
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 66
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 64
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 64
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 64
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 64
The emerging role of insulin receptor isoforms in thyroid cancer: Clinical implications and new perspectives 64
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 64
Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection 64
Editorial: Early diagnoses and treatments of uncommon breast cancers 63
Thyrospheres an in vitro model for human thyroid carcinogenesis 62
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 61
Type 3 deiodinase: Role in cancer growth, stemness, and metabolism 60
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 59
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 59
COVID-19 and Diabetes: The Importance of Controlling RAGE 59
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 58
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 58
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 57
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 55
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 55
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 55
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 54
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 54
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 52
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 52
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 51
Role of BRAF(V600) mutation in the resistance to gefinitib of thyroid cancer cells. 51
Editorial: Resistance to Endocrine Therapies in Cancer 51
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 50
Long-acting insulin analogs and cancer 47
REGULATION OF mirRNAS BY p53 FAMILIY MEMBERS IN THYROID CANCER CELLS 46
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 45
REACTIVATION OF P53 MUTANTS BY SMALL COMPOUNDS MAY REPRESENT AN ADJUVANT THERAPY OF POORLY DIFFERENTIATED THYROID CANCER 45
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 44
EGFR INHIBITION ENHANCES THE SENSITIVITY OF POORLY DIFFERENTIATED THYROID CANCER CELLS TO CHEMOTHERAPY 44
Levels of histone acetylation in thyroid tumors 43
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 42
Short-term adverse affects of anticancer drugs in type 2 diabetes patients. 42
P63 EXPRESSION AND FUNCTION IN THYROID CANCER 42
Manuale di endocrinologia geriatrica 41
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 39
Identification of Thyroid Cancer Stem Cells 38
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 34
Metyrapone restores nocturnal cortisol profile and impaired post-dexamethasone suppression in mild autonomous cortisol secretion due to bilateral adrenal incidentaloma 32
Editorial: A year in review: discussions in cancer endocrinology 30
Totale 6.251
Categoria #
all - tutte 23.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.128


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021406 0 0 33 2 98 7 43 12 105 9 57 40
2021/2022555 49 91 15 7 82 3 82 29 42 0 17 138
2022/20231.252 82 43 36 155 124 182 34 230 269 24 40 33
2023/2024639 22 124 24 53 19 134 7 67 13 26 87 63
2024/20252.285 109 434 103 216 419 233 73 74 171 143 177 133
2025/2026535 240 217 78 0 0 0 0 0 0 0 0 0
Totale 6.251